#Vascular Graft market

[stanleyhuds]

Vascular Grafts Market Size, Share, Demand, Growth, and Forecast 2025-2033

Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

The global vascular grafts market size reached USD 2.0 Billion in 2024.

The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.

North America leads the market, accounting for the largest vascular grafts market share.

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

The ongoing technological advancements in graft materials and design are supporting the market growth.

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

Prevalence of Cardiovascular Diseases:

The rising global cases of cardiovascular diseases (CVDs) are boosting market growth. These diseases often need surgery that uses vascular grafts.

Technological Advancements in Graft Materials and Design:

Technological progress in graft materials and designs is boosting the market. Today's vascular grafts are biocompatible, durable, and reduce complications like infections and rejection. Innovations such as drug-eluting and tissue-engineered grafts are also emerging. These grafts aim to better integrate with the body's tissues. Such advancements improve the safety and effectiveness of vascular surgeries, thus enhancing patient outcomes.

Preference for Minimally Invasive Surgeries (MIS):

Minimally invasive surgeries (MIS) are driving market growth. Procedures like endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) are less invasive than traditional surgeries. They also reduce hospital stays, lower infection risks, and speed up recovery. This boosts interest in specialized vascular grafts for these surgeries. Moreover, patients and doctors are leaning towards MIS for its benefits. This trend increases the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

Endovascular Stent Grafts

Hemodialysis Access Grafts

Coronary Artery By-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

Polytetrafluoroethylene (PTFE)

Polyester

Polyurethane

Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

Cardiac Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

Abbott Laboratories

B. Braun SE (B. Braun Holding GmbH & Co. KG)

Becton, Dickinson & Company

Cook Group Incorporated

Cordis

CryoLife Inc.

Getinge AB

Heat Medical Europe BV

LeMaitre Vascular

Medtronic plc

Terumo Corporation

W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 

[businessresearchreportss]

Key Players and Manufacturers in the Vascular Grafts Market: Leading Companies and Market Share Analysis

The vascular grafts market is comprised of several key players and manufacturers, with a few leading companies dominating the market.

Buy the Full Report for More Insights into the Vascular Grafts Market Forecast

Download a Free Sample Report

Here are some of the prominent players and their market share analysis:

Medtronic plc:

Medtronic is a global leader in medical technology, offering a wide range of vascular products, including vascular grafts.

The company's vascular graft portfolio includes both synthetic and biological grafts used in vascular surgery.

Medtronic holds a significant market share in the vascular grafts market, owing to its extensive product offerings and global presence.

Terumo Corporation:

Terumo Corporation is a Japanese multinational company that manufactures medical devices and equipment, including vascular grafts.

The company offers a range of vascular graft products for various applications, such as hemodialysis access and peripheral vascular surgery.

Terumo Corporation holds a considerable market share, particularly in Asia-Pacific regions.

Getinge AB:

Getinge AB, headquartered in Sweden, is a leading global provider of medical technology products and solutions, including vascular grafts.

The company's vascular graft portfolio includes synthetic grafts for vascular reconstructions and bypass surgeries.

Getinge AB has a significant presence in the European vascular grafts market and holds a notable market share in the industry.

B. Braun Melsungen AG:

B. Braun is a German medical and pharmaceutical company that manufactures a wide range of healthcare products, including vascular grafts.

The company offers vascular graft solutions for cardiovascular and peripheral vascular surgeries, catering to both synthetic and biological graft requirements.

B. Braun holds a considerable market share, particularly in Europe and other regions where its products are distributed.

LeMaitre Vascular, Inc.:

LeMaitre Vascular is a leading global provider of devices for the treatment of peripheral vascular diseases.

The company offers a diverse portfolio of vascular grafts, including prosthetic and biological grafts, used in peripheral vascular procedures.

While smaller compared to some other players, LeMaitre Vascular has been gaining market share steadily, particularly in the peripheral vascular segment.

Cook Medical Inc.:

Cook Medical is a privately held medical device company headquartered in the United States, specializing in minimally invasive medical technologies.

The company manufactures vascular grafts, including synthetic grafts for vascular access and reconstruction procedures.

Cook Medical holds a notable market share in the vascular grafts market, particularly in North America.

Market share analysis for these companies can vary by region and product segment within the vascular grafts market. However, these players are among the leading manufacturers in the industry, each contributing significantly to the market's overall growth and development.

[marketsizereports]

Emerging Technologies and Innovations in the North America Aortic and Vascular Graft Procedures Market

The North America Aortic and Vascular Graft Procedures market has been witnessing significant advancements in technology and innovation. These emerging technologies are aimed at improving patient outcomes, reducing complications, and enhancing the overall efficacy of aortic and vascular graft procedures. Here are some notable innovations in this field:

Endovascular Aneurysm Repair (EVAR): EVAR is a minimally invasive procedure used to treat abdominal aortic aneurysms (AAAs). It involves the placement of a stent graft within the aorta to reinforce the weakened vessel walls and prevent aneurysm rupture. EVAR has gained popularity due to its reduced invasiveness, shorter recovery times, and lower mortality rates compared to open surgical repair.

Fenestrated and Branched Endovascular Aortic Repair (FEVAR and BEVAR): FEVAR and BEVAR are advanced techniques used to treat complex aortic aneurysms that involve the renal arteries or other branch vessels. These procedures utilize custom-made stent grafts with fenestrations or branches that align with the patient's specific anatomy, allowing for precise deployment and preservation of blood flow to vital organs.

Bioactive and Biodegradable Grafts: Bioactive grafts are designed to stimulate tissue regeneration and promote healing. They may incorporate growth factors or coatings that encourage the body's natural healing processes, leading to better integration of the graft and reduced risk of complications. Biodegradable grafts are gradually absorbed by the body over time, eliminating the need for long-term implant presence and potentially reducing the risk of infection or graft-related complications.

3D Printing and Patient-Specific Grafts: 3D printing technology enables the creation of patient-specific grafts tailored to individual anatomical requirements. This customization improves the accuracy of graft placement and ensures optimal fit and functionality. Patient-specific grafts can be designed to match complex anatomies, making them particularly useful in treating aortic aneurysms with challenging geometries.

Advanced Imaging Techniques: High-resolution imaging techniques such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA) play a crucial role in the diagnosis, planning, and post-operative evaluation of aortic and vascular graft procedures. These imaging modalities provide detailed visualization of the vasculature, aiding in precise graft sizing, placement, and surveillance.

Robotic-Assisted Surgery: Robotic-assisted surgical systems offer enhanced precision and dexterity to surgeons performing aortic and vascular graft procedures. These systems allow for smaller incisions, improved visualization, and greater maneuverability of surgical instruments. Robotic-assisted surgery can contribute to reduced trauma, faster recovery, and improved patient outcomes.

Nanotechnology: Nanotechnology has the potential to revolutionize aortic and vascular graft procedures. Nanomaterials, such as carbon nanotubes and nanofibers, can be incorporated into grafts to enhance their mechanical properties, promote cellular adhesion, and provide controlled drug release for targeted therapies. Nanotechnology-based approaches may lead to improved graft durability, reduced complications, and enhanced tissue regeneration.

For more insights on the North America Aortic and Vascular Graft Procedures market category analysis, download a free report sample

These emerging technologies and innovations in the North America Aortic and Vascular Graft Procedures market are driving advancements in the field, offering new treatment options, improving patient outcomes, and shaping the future of vascular surgery. Continued research and development in these areas hold the potential to further enhance the safety, efficacy, and long-term success of aortic and vascular graft procedures.

[market-insider]

Vascular Grafts Market Boosted By Rising Number Of Chronic Kidney Diseases, Heart Attacks And Atherosclerotic Heart Diseases

The global vascular grafts market size is anticipated to reach USD 3.1 billion by 2030 and is expected to expand at a CAGR of 7.0% during the forecast period, according to a new report by Grand View Research, Inc. The rising number of dialysis procedures and prevalence of chronic kidney diseases, heart attacks, atherosclerotic heart diseases, and stroke is boosting the adoption of vascular grafts. Moreover, the rising demand for minimally invasive surgeries among the population is impelling the market growth.

Furthermore, the increasing medical applications and developments in intraoperative techniques are driving the market. Peripheral vascular disease affects more than 200 million people worldwide. This is anticipated to raise the demand for vascular grafts during the forecast period. The outbreak of COVID-19 had a negative impact on the market growth due to the deferrals in non-essential medical procedures. It also affected the sales and operation of companies.

Gain deeper insights on the market and receive your free copy with TOC now @: Vascular Grafts Market Report

In 2021, the endovascular stent-graft products segment dominated the market with a revenue share of 63.8% due to its increasing adoption in response to the rising cases of aortic aneurysms. According to the data published by CDC, in 2019, about 9,904 deaths were witnessed due to aortic aneurysms in the United States. An unhealthy lifestyle has raised the prevalence of cardiac diseases and renal disease, thereby impelling the market growth.

Additionally, the increasing geriatric population and rising disposable income coupled with healthcare expenditure in emerging countries is contributing to market growth in these regions. The peripheral vascular grafts segment is expected to grow at the fastest rate due to increasing use in peripheral artery bypass. Also, the rising cases of hardening of arteries is boosting the demand for peripheral vascular graft.

The cardiac aneurysm application segment held the majority share in 2021 owing to the rising cases of raised blood pressure, hyperglycemia, hypercholesterolemia, etc. Also, the rising geriatric population and increasing cases of atherosclerotic heart diseases among the population are impelling the market growth. Moreover, the shifting trend toward minimally invasive treatments has raised the adoption of minimally invasive vascular implants to treat cardiac aneurysms, thereby boosting the segment growth.

On the other hand, the vascular occlusion application segment is anticipated to witness the fastest growth rate due to the increasing prevalence of vascular occlusion disease and the availability of graft procedures. Moreover, the development of novel therapies to treat vascular occlusion is anticipated to drive the market during the forecast period.

As of 2021, the polytetrafluoroethylene raw material segment held the majority share in the market and is expected to witness the fastest growth rate during the forecast period. The growth is attributed to its capability of tolerating pressures and flows in large and medium arteries; moreover, it offers low degradation and infection risk.     The key players offering innovative products that offer maximum protection and help reduce the pain is impelling the market growth. For instance, Biovic offers AVATAR PTFE Vascular Graft. It is developed using Humidity Resistant Technology and has porous microstructure on both internal and external surfaces to maximize tissue in-growth and healing response.

[ustechbog]

A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. The peripheral vascular stents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development.

[willyskristina]

Embolic Protection Devices Market

Embolic Protection Devices Market Size, Share, Trends: Medtronic plc Leads

Rising Adoption of TAVR Procedures Drives Demand for Embolic Protection

Market Overview:

The Embolic Protection Devices Market is projected to grow at a CAGR of 8.2% from 2024 to 2031. North America currently dominates the market, with the highest market share and revenue. Key metrics include the increasing prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, and technological advancements in embolic protection devices. The market is experiencing significant growth due to the rising incidence of cardiovascular and neurovascular diseases globally. Embolic protection devices play a crucial role in preventing complications during endovascular procedures, driving their adoption in healthcare settings. The increasing geriatric population and the growing demand for effective treatment options for vascular diseases are also contributing to market expansion.

DOWNLOAD FREE SAMPLE

Market Trends:

A significant trend driving the embolic protection devices market is the rising adoption of transcatheter aortic valve replacement (TAVR) procedures. TAVR has emerged as a minimally invasive alternative to traditional open-heart surgery for treating severe aortic stenosis, particularly in high-risk patients. As TAVR procedures gain popularity, the demand for embolic protection devices has surged to mitigate the risk of periprocedural stroke and other embolic complications. The growing acceptance of TAVR among patients and healthcare providers, supported by expanding indications for its use in lower-risk patients, has led to substantial increases in procedure volumes worldwide.

Market Segmentation:

Distal filter devices currently hold the largest market share in the embolic protection devices segment. These devices are widely preferred due to their ability to capture and remove embolic debris while maintaining blood flow during endovascular procedures. Their versatility across various applications, including carotid artery stenting, saphenous vein graft interventions, and TAVR, contributes to their dominance. Recent advancements in distal filter technology, such as improved capture efficiency and lower crossing profiles, have enhanced their performance and ease of use. Industry leaders such as Boston Scientific Corporation and Medtronic plc have reported significant growth in their embolic protection portfolios, driven by the strong performance of their distal filter devices.

Market Key Players:

The embolic protection devices market is highly competitive, with major players focusing on technological innovation and strategic alliances. Key companies such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cardinal Health, Inc., Silk Road Medical, Inc., and W. L. Gore & Associates, Inc. are at the forefront, driving innovation and setting trends in the market. These firms invest heavily in R&D to introduce advanced embolic protection devices tailored to the needs of healthcare providers.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[marketinsightsbusiness]

The Future of Vascular Grafts: A Lifesaving Revolution

Vascular grafts are transforming cardiovascular care, offering hope to millions suffering from coronary artery disease, aneurysms, and renal failure. With advancements like biocompatible materials, 3D printing, and bioengineered grafts, patient outcomes are improving significantly. However, challenges like high costs and accessibility persist, especially in developing regions. The vascular graft market, driven by an aging population and rising cardiovascular disease cases, is poised for remarkable growth. Continued innovation and collaboration will ensure these critical devices become more accessible worldwide.

Download Sample Report...